Modelis is expediting the journey from drug discovery to clinical trials where traditional approaches aren’t practical and feasible. We do this by leveraging our in vivo, AI-driven data platform to unlock insights which we can turn into new treatments for rare and complex genetic disorders with unmet needs. Modelis’ platform will only get smarter, compiling information and insight at every turn in an ever-revolving cycle of data generation and computational analysis, leading to the development of disease insights, and the discovery of new therapies and cures.